Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiro Saito

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Scientific Reports|July 13, 2023
Extremely large lamb shift in a deep-strongly coupled circuit QED system with a multimode resonatorZiqiao Ao, Sahel Ashhab, Fumiki Yoshihara, et al.
Clinical Genitourinary Cancer|May 30, 2016
Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?Naoya Niwa, Eiji Kikuchi, Matsushima Masashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 30, 2017
Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation databaseKoji Okihara, Atsunori Yorozu, Shiro Saito, et al.
Endocrine Pathology|July 1, 1997
Multiple Endocrine Neoplasms in a Patient with AL Amyloidosis-Associated Plasma Cell DyscrasiaKunihiko Seki, Shingo Wakatsuki, Kazuo Hizawa, et al.
Brachytherapy|October 18, 2020
Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score-matched analysisShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2006
[Brachytherapy for prostate cancer]Atsunori Yorozu, Kazuhito Toya, Toshio Ohashi, et al.
Brachytherapy|September 25, 2018
Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapyNaoya Niwa, Kazuhiro Matsumoto, Toru Nishiyama, et al.
BJU International|February 12, 2005
A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern JapanTakahiko Hachiya, Koichiro Akakura, Shiro Saito, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 31, 2004
[Implementation of a common clinical path for transurethral resection of prostate (TURP) in multiple hospitals]Kikuo Okamura, Hideo Ozawa, Tsuneo Kinukawa, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 7, 2018
Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort studyKatsumasa Nakamura, Saiji Ohga, Atsunori Yorozu, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Scientific Reports|July 13, 2023
Extremely large lamb shift in a deep-strongly coupled circuit QED system with a multimode resonatorZiqiao Ao, Sahel Ashhab, Fumiki Yoshihara, et al.
Clinical Genitourinary Cancer|May 30, 2016
Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?Naoya Niwa, Eiji Kikuchi, Matsushima Masashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 30, 2017
Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation databaseKoji Okihara, Atsunori Yorozu, Shiro Saito, et al.
Endocrine Pathology|July 1, 1997
Multiple Endocrine Neoplasms in a Patient with AL Amyloidosis-Associated Plasma Cell DyscrasiaKunihiko Seki, Shingo Wakatsuki, Kazuo Hizawa, et al.
Brachytherapy|October 18, 2020
Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score-matched analysisShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2006
[Brachytherapy for prostate cancer]Atsunori Yorozu, Kazuhito Toya, Toshio Ohashi, et al.
Brachytherapy|September 25, 2018
Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapyNaoya Niwa, Kazuhiro Matsumoto, Toru Nishiyama, et al.
BJU International|February 12, 2005
A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern JapanTakahiko Hachiya, Koichiro Akakura, Shiro Saito, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 31, 2004
[Implementation of a common clinical path for transurethral resection of prostate (TURP) in multiple hospitals]Kikuo Okamura, Hideo Ozawa, Tsuneo Kinukawa, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 7, 2018
Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort studyKatsumasa Nakamura, Saiji Ohga, Atsunori Yorozu, et al.
Pageof 12